Accendra Health Inc/Va/: Pay

Accendra Health Inc/Va/ paid its 5 named executives $23.4M in total in FY2025 (Dec). CEO Andrew G. Long was paid $3.6M of that.

PayNo stock prices for these years
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Edward A. PesickaPresident & Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Andrew G. LongExecutive Vice President, Chief Executive Officer, Products & Healthcare Services
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Perry A. BernocchiExecutive Vice President, Chief Operating Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years
Jonathan A. LeonExecutive Vice President & Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
2 years
Heath H. GallowayExecutive Vice President, General Counsel & Corporate Secretary
FY2025 (Dec)
FY2024 (Dec)
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 9 peers with pay on file was $12.3M. CEO pay of Accendra Health Inc/Va/ for that year is not on file.

  1. 1Boston Scientific
  2. 2Zimmer Biomet Holdings
  3. 3Quest Diagnostics
  4. 4Resmed
  5. 5Wesco International
  6. 6Henry Schein
  7. 7STERIS
  8. 8AdaptHealth
  9. 9Dentsply Sirona
  10. 10Accendra Health Inc/Va/Not disclosed
  11. 11Baxter InternationalNot disclosed
  12. 12C.H. Robinson Worldwide, Inc.Not disclosed
  13. 13Hologic, Inc.Not disclosed
  14. 14Patterson Companies, Inc.Not disclosed
  15. 15Select Medical Holdings CorporationNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.